World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
69
Citations
18022
World Ranking
7347
National Ranking
5

Medicine

D-Index
72
Citations
19721
World Ranking
19821
National Ranking
1

Mario Poljak publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Mario Poljak sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 451 publications — 93rd percentile

93% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Mario Poljak D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Mario Poljak sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 69 D-Index — 63rd percentile

63% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Mario Poljak is affiliated with the University of Ljubljana in Slovenia and has contributed extensively to the field of medicine, with a primary focus on epidemiology, infectious diseases, molecular biology, surgery, and oncology. Their research encompasses a range of topics including cervical cancer and HPV research, genital health and disease, molecular biology techniques and applications, hepatitis B virus studies, SARS-CoV-2 and COVID-19 research, global cancer incidence and screening, and herpesvirus infections and treatments.

Their recent publications include:

  • "Cervical cancer screening programmes and age-specific coverage estimates for 202 countries and territories worldwide: a review and synthetic analysis" (2022, The Lancet Global Health)
  • "2020 list of human papillomavirus assays suitable for primary cervical cancer screening" (2021, Clinical Microbiology and Infection)
  • "Clinical Evaluation of the cobas SARS-CoV-2 Test and a Diagnostic Platform Switch during 48 Hours in the Midst of the COVID-19 Pandemic" (2020, Journal of Clinical Microbiology)
  • "Commercially available molecular tests for human papillomaviruses: a global overview" (2020, Clinical Microbiology and Infection)
  • "Cervical screening: ESGO-EFC position paper of the European Society of Gynaecologic Oncology (ESGO) and the European Federation of Colposcopy (EFC)" (2020, British Journal of Cancer)

Frequent co-authors of Mario Poljak include:

  • Anja Oštrbenk Valenčak (20 co-authored works)
  • Tomaž Mark Zorec (20 co-authored works)
  • Marc Arbyn (19 co-authored works)
  • Miša Korva (17 co-authored works)
  • Lea Hošnjak (17 co-authored works)

Preferred publication venues consist mainly of:

  • Journal of Clinical Virology (10 publications)
  • Viruses (9 publications)
  • Acta Dermatovenerologica Alpina Pannonica et Adriatica (8 publications)
  • Clinical Microbiology and Infection (6 publications)
  • Journal of Clinical Microbiology (4 publications)

Mario Poljak's work is predominantly situated within the broader field of medicine, with a particular emphasis on epidemiological patterns and molecular investigations relevant to viral infections and cancer screening strategies. The combination of collaborative efforts with other researchers and dissemination through reputable scientific journals supports the reach and impact of their research. The broad thematic areas addressed in their publications reflect an interdisciplinary approach to understanding infectious agents, diagnostic methodologies, and disease prevention mechanisms.

Best Publications

  • Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer.

    Marc Arbyn;Guglielmo Ronco;Ahti Anttila;Chris J.L.M. Meijer

  • HPV Involvement in Head and Neck Cancers: Comprehensive Assessment of Biomarkers in 3680 Patients

    Xavier Castellsagué;Laia Alemany;Miquel Quer;Gordana Halec

  • Comprehensive control of human papillomavirus infections and related diseases.

    F. Xavier Bosch;Thomas R. Broker;David Forman;Anna Barbara Moscicki

  • Human papillomavirus DNA prevalence and type distribution in anal carcinomas worldwide.

    Laia Alemany;Maëlle Saunier;Isabel Alvarado-Cabrero;Beatriz Quirós

  • Which high-risk HPV assays fulfil criteria for use in primary cervical cancer screening?

    M. Arbyn;P.J.F. Snijders;C.J.L.M. Meijer;J. Berkhof

  • Transmission of Drug-Resistant HIV-1 Is Stabilizing in Europe

    Jurgen Vercauteren;Annemarie M. J. Wensing;David A. M. C. van de Vijver;Jan Albert

  • Geographic and temporal trends in the molecular epidemiology and genetic mechanisms of transmitted HIV-1 drug resistance: an individual-patient- and sequence-level meta-analysis

    Soo Yon Rhee;Jose Luis Blanco;Michael R. Jordan;Jonathan Taylor

  • Hybrid Capture II HPV Test detects at least 15 human papillomavirus genotypes not included in its current high-risk probe cocktail.

    Mario Poljak;Irena J Marin;Katja Seme;Adriana Vince

  • Primary HPV-based cervical cancer screening in Europe: implementation status, challenges, and future plans.

    P.J. Maver;M. Poljak

  • Geographical and temporal distribution of SARS-CoV-2 clades in the WHO European Region, January to June 2020.

    Erik Alm;Eeva K Broberg;Thomas Connor;Emma B Hodcroft

  • HPV-FASTER: broadening the scope for prevention of HPV-related cancer.

    F. Xavier Bosch;Claudia Robles;Mireia Díaz;Marc Arbyn

  • Transmission of HIV Drug Resistance and the Predicted Effect on Current First-line Regimens in Europe

    L. Marije Hofstra;Nicolas Sauvageot;Jan Albert;Jan Albert;Ivailo Alexiev

  • European recommendations for the clinical use of HIV drug resistance testing: 2011 update

    Anne-Mieke Vandamme;Ricardo J Camacho;Francesca Ceccherini-Silberstein;Andreu de Luca;Andreu de Luca

  • HIV-1 subtype distribution and its demographic determinants in newly diagnosed patients in Europe suggest highly compartmentalized epidemics

    Ana B. Abecasis;Annemarie M.J. Wensing;Dimitris Paraskevis;Jurgen Vercauteren;Jurgen Vercauteren

  • 2020 list of human papillomavirus assays suitable for primary cervical cancer screening.

    Marc Arbyn;Marie Simon;Eliana Peeters;Lan Xu

  • Antimicrobial resistance and antibiotic stewardship programs in the ICU: insistence and persistence in the fight against resistance. A position statement from ESICM/ESCMID/WAAAR round table on multi-drug resistance

    Jan J.J. De Waele;Murat Akova;Massimo Antonelli;Rafael Canton

  • Transmission of Mycobacterium tuberculosis from Human to Cattle

    Matjaz Ocepek;Mateja Pate;Manca Zolnir-Dovc;Mario Poljak

  • Update from the 4th Edition of the World Health Organization Classification of Head and Neck Tumours: What is New in the 2017 WHO Blue Book for Tumours of the Hypopharynx, Larynx, Trachea and Parapharyngeal Space.

    Nina Gale;Mario Poljak;Nina Zidar

  • Current review on squamous intraepithelial lesions of the larynx.

    Nina Gale;Leslie Michaels;Bostjan Luzar;Mario Poljak

  • VALGENT: A protocol for clinical validation of human papillomavirus assays

    Marc Arbyn;Christophe Depuydt;Ina Benoy;Johannes Bogers

Frequent Co-Authors

Marc Arbyn
Marc Arbyn Ghent University
Anne-Mieke Vandamme
Anne-Mieke Vandamme Rega Institute for Medical Research
Charles A. Boucher
Charles A. Boucher Erasmus University Rotterdam
Joakim Dillner
Joakim Dillner Karolinska University Hospital
Dimitrios Paraskevis
Dimitrios Paraskevis National and Kapodistrian University of Athens
Annemarie M. J. Wensing
Annemarie M. J. Wensing Utrecht University
Anders Sönnerborg
Anders Sönnerborg Karolinska Institute
Jan Albert
Jan Albert Karolinska Institute
Claudia Balotta
Claudia Balotta University of Milan
David A. M. C. van de Vijver
David A. M. C. van de Vijver Erasmus University Rotterdam

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Mario Poljak

Trending Scientists

Recently Published Articles